Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of Subcutaneous AZD6912 in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneous AZD6912 in healthy participants; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• AZD6912

Snippet

Sponsor: AstraZeneca | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED